Bain Capital Life Sciences Opportunities III, LP 13D and 13G filings for Cara Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 6:50 pm Sale |
2023-12-31 | 13G | Cara Therapeutics, Inc. CARA |
Bain Capital Life Sciences Opportunities III, LP | 0 0.000% |
-224,669 (Position Closed) |
Filing |
| 2022-11-18 4:16 pm Purchase |
2022-11-09 | 13G | Cara Therapeutics, Inc. CARA |
Bain Capital Life Sciences Opportunities III, LP | 224,669 5.000% |
224,669 (New Position) |
Filing |